Previous Article | Next Article 
Journal of Virology, May 2007, p. 4973-4980, Vol. 81, No. 10
0022-538X/07/$08.00+0 doi:10.1128/JVI.02362-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Epitope-Dependent Avidity Thresholds for Cytotoxic T-Lymphocyte Clearance of Virus-Infected Cells
Michael S. Bennett,1
Hwee L. Ng,2
Mirabelle Dagarag,2
Ayub Ali,2 and
Otto O. Yang1,2*
Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, California 90095,1
Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California 900952
Received 27 October 2006/
Accepted 21 February 2007
Cytotoxic T lymphocytes (CTLs) are crucial for immune control of viral infections. "Functional avidity," defined by the sensitizing dose of exogenously added epitope yielding half-maximal CTL triggering against uninfected target cells (SD50), has been utilized extensively as a measure of antiviral efficiency. However, CTLs recognize infected cells via endogenously produced epitopes, and the relationship of SD50 to antiviral activity has never been directly revealed. We elucidate this relationship by comparing CTL killing of cells infected with panels of epitope-variant viruses to the corresponding SD50 for the variant epitopes. This reveals a steeply sigmoid relationship between avidity and infected cell killing, with avidity thresholds (defined as the SD50 required for CTL to achieve 50% efficiency of infected cell killing [KE50]), below which infected cell killing rapidly drops to none and above which killing efficiency rapidly plateaus. Three CTL clones recognizing the same viral epitope show the same KE50 despite differential recognition of individual epitope variants, while CTLs recognizing another epitope show a 10-fold-higher KE50, demonstrating epitope dependence of KE50. Finally, the ability of CTLs to suppress viral replication depends on the same threshold KE50. Thus, defining KE50 values is required to interpret the significance of functional avidity measurements and predict CTL efficacy against virus-infected cells in pathogenesis and vaccine studies.
* Corresponding author. Mailing address: Division of Infectious Diseases, 37-121 CHS, UCLA Medical Center, 10833 LeConte Ave., Los Angeles, CA 90095. Phone: (310) 794-9491. Fax: (310) 825-3632. E-mail:
oyang{at}mednet.ucla.edu
Published ahead of print on 28 February 2007.
Journal of Virology, May 2007, p. 4973-4980, Vol. 81, No. 10
0022-538X/07/$08.00+0 doi:10.1128/JVI.02362-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Chen, H., Piechocka-Trocha, A., Miura, T., Brockman, M. A., Julg, B. D., Baker, B. M., Rothchild, A. C., Block, B. L., Schneidewind, A., Koibuchi, T., Pereyra, F., Allen, T. M., Walker, B. D.
(2009). Differential Neutralization of Human Immunodeficiency Virus (HIV) Replication in Autologous CD4 T Cells by HIV-Specific Cytotoxic T Lymphocytes. J. Virol.
83: 3138-3149
[Abstract]
[Full Text]
-
Youn, J.-W., Hu, Y.-W., Tricoche, N., Pfahler, W., Shata, M. T., Dreux, M., Cosset, F.-L., Folgori, A., Lee, D.-H., Brotman, B., Prince, A. M.
(2008). Evidence for Protection against Chronic Hepatitis C Virus Infection in Chimpanzees by Immunization with Replicating Recombinant Vaccinia Virus. J. Virol.
82: 10896-10905
[Abstract]
[Full Text]
-
Simons, B. C., VanCompernolle, S. E., Smith, R. M., Wei, J., Barnett, L., Lorey, S. L., Meyer-Olson, D., Kalams, S. A.
(2008). Despite Biased TRBV Gene Usage against a Dominant HLA B57-Restricted Epitope, TCR Diversity Can Provide Recognition of Circulating Epitope Variants. J. Immunol.
181: 5137-5146
[Abstract]
[Full Text]
-
Sacha, J. B., Reynolds, M. R., Buechler, M. B., Chung, C., Jonas, A. K., Wallace, L. T., Weiler, A. M., Lee, W., Piaskowski, S. M., Soma, T., Friedrich, T. C., Wilson, N. A., Watkins, D. I.
(2008). Differential Antigen Presentation Kinetics of CD8+ T-Cell Epitopes Derived from the Same Viral Protein. J. Virol.
82: 9293-9298
[Abstract]
[Full Text]
-
Walker, B. D., Burton, D. R.
(2008). Toward an AIDS Vaccine. Science
320: 760-764
[Abstract]
[Full Text]
-
Turk, G., Gherardi, M. M., Laufer, N., Saracco, M., Luzzi, R., Cox, J. H., Cahn, P., Salomon, H.
(2008). Magnitude, Breadth, and Functional Profile of T-Cell Responses during Human Immunodeficiency Virus Primary Infection with B and BF Viral Variants. J. Virol.
82: 2853-2866
[Abstract]
[Full Text]
-
Valentine, L. E., Piaskowski, S. M., Rakasz, E. G., Henry, N. L., Wilson, N. A., Watkins, D. I.
(2008). Recognition of Escape Variants in ELISPOT Does Not Always Predict CD8+ T-Cell Recognition of Simian Immunodeficiency Virus-Infected Cells Expressing the Same Variant Sequences. J. Virol.
82: 575-581
[Abstract]
[Full Text]
-
Liu, Y., McNevin, J., Zhao, H., Tebit, D. M., Troyer, R. M., McSweyn, M., Ghosh, A. K., Shriner, D., Arts, E. J., McElrath, M. J., Mullins, J. I.
(2007). Evolution of Human Immunodeficiency Virus Type 1 Cytotoxic T-Lymphocyte Epitopes: Fitness-Balanced Escape. J. Virol.
81: 12179-12188
[Abstract]
[Full Text]